Undisclosed HCC therapeutic
/ J & D Pharmaceuticals
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 04, 2025
J & D Pharmaceuticals LLC Receives Orphan Drug Designation for Treatment of Hepatocellular Carcinoma (HCC)
(PRNewswire)
Orphan drug • Hepatocellular Cancer
1 to 1
Of
1
Go to page
1